Acquiring Company
Gilead Sciences
Acquired Company
MiroBio
Foster CityBiotechnologyHealth CareTherapeuticsBiopharmaBiotechnologyHealth CareDescription
Gilead Sciences, Inc. (Nasdaq: GILD) and MiroBio, a privately-held U.K.-based biotechnology company focused on restoring immune balance with agonists targeting immune inhibitory receptors, today announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire MiroBio for approximately $405 million in cash, subject to customary adjustments.
Quick answer
Gilead Sciences is acquiring MiroBio, announced August 4, 2022. Gilead Sciences is based in Foster City, California, United States.
- How much did Gilead Sciences pay for MiroBio?
- The deal value was not disclosed.
- What does Gilead Sciences do?
- Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.
- Where are Gilead Sciences and MiroBio based?
- Gilead Sciences is based in Foster City, California, United States.
- Who are the decision-makers at Gilead Sciences?
- Fundz holds 1 contact at Gilead Sciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Biopharma
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Bristol Myers Squibb And Turning Point Therapeutics Announce Expiration Of Hsr Act Waiting Period And Clearance From Federal Cartel Office Of Germany Related To Pending Acquisition Of Turning Point Therapeutics (August 16, 2022)
- Bristol Myers Squibb Completes Acquisition Of Turning Point Therapeutics, Expanding Precision Oncology Portfolio (August 17, 2022)
- Pfizer To Acquire Global Blood Therapeutics For $5.4 Billion To Enhance Presence In Rare Hematology, $5.4B (August 8, 2022)
- Gurnet Point Capital And Patient Square Capital Complete Their Acquisition Of Radius Health, Inc. (August 15, 2022)
- Amgen To Acquire Chemocentryx For $4 Billion In Cash, $4B (August 4, 2022)
- Rafa Laboratories To Acquire A Significant Stake In Exceed Orphan And Expand Its International Capabilities In Medicines Addressing Rare Diseases (August 1, 2022)
Who to call at Gilead Sciences, and when
When Gilead Sciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Gilead Sciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Gilead Sciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Gilead Sciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Gilead Sciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired MiroBio?
MiroBio was acquired by Gilead Sciences, based in Foster City. The deal was reported on August 4, 2022. Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. Gilead Sciences is publicly traded (GILD) and operates in Biotechnology.
When did Gilead Sciences acquire MiroBio?
Gilead Sciences's acquisition of MiroBio was reported on August 4, 2022. Gilead Sciences, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does MiroBio do?
MiroBio is a clinical-stage private biotechnology company whose mission is to develop a new class of therapeutic agents, checkpoint agonist antibodies, to restore immune balance in autoimmune patients. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.